|  | hsa-miR-125a-3p | ||
---|---|---|---|---|
Variable | Patients | Low expression(%) | High expression(%) | p value |
Gender | Â | Â | Â | Â |
Male | 33 | 12 (36.4) | 21 (63.6) | Â |
Female | 19 | 6 (31.6) | 13 (68.4) | 0.727b |
Age | Â | Â | Â | Â |
≤ 60 | 28 | 22 (78.6) | 6 (21.4) |  |
> 60 | 24 | 12 (50.0) | 12 (50.0) | 0.031b |
Histology type | Â | Â | Â | Â |
Squamous cancer | 22 | 13 (59.1) | 9 (40.9) | Â |
Adenocarcinoma | 30 | 21 (70.0) | 9 (30.0) | 0.414b |
Pathological grade | Â | Â | Â | Â |
I | 8 | 7 (87.5) | 1 (12.5) | Â |
II | 28 | 17 (60.7) | 11 (39.3) | Â |
III | 16 | 10 (62.5) | 6 (37.5) | 0.370c |
Pathological stage | Â | Â | Â | Â |
I | 18 | 8 (44.4) | 10 (55.6) | Â |
II | 15 | 10 (66.7) | 5 (33.3) | Â |
III | 19 | 16 (80.0) | 3 (20.0) | 0.012c |
Lymph node status | Â | Â | Â | Â |
No metastasis | 32 | 17 (53.1) | 15 (46.9) | Â |
Metastasis | 20 | 17 (85.0) | 3 (15.0) | 0.034a |